Logo image of CGTL

CREATIVE GLOBAL TECHNOLOGY-A (CGTL) Stock Fundamental Analysis

NASDAQ:CGTL - Nasdaq - KYG2563P1028 - Common Stock - Currency: USD

0.9113  +0.08 (+9.5%)

After market: 0.935 +0.02 (+2.6%)

Fundamental Rating

6

Taking everything into account, CGTL scores 6 out of 10 in our fundamental rating. CGTL was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. CGTL has an excellent financial health rating, but there are some minor concerns on its profitability. CGTL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CGTL had positive earnings in the past year.
CGTL had a negative operating cash flow in the past year.
CGTL Yearly Net Income VS EBIT VS OCF VS FCFCGTL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M -2M 4M

1.2 Ratios

CGTL has a better Return On Assets (35.61%) than 99.20% of its industry peers.
With an excellent Return On Equity value of 43.18%, CGTL belongs to the best of the industry, outperforming 97.60% of the companies in the same industry.
CGTL has a better Return On Invested Capital (43.31%) than 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CGTL is significantly above the industry average of 9.30%.
The last Return On Invested Capital (43.31%) for CGTL is above the 3 year average (40.34%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 35.61%
ROE 43.18%
ROIC 43.31%
ROA(3y)32%
ROA(5y)N/A
ROE(3y)40.9%
ROE(5y)N/A
ROIC(3y)40.34%
ROIC(5y)N/A
CGTL Yearly ROA, ROE, ROICCGTL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 20 40 60 80

1.3 Margins

Looking at the Profit Margin, with a value of 10.35%, CGTL belongs to the top of the industry, outperforming 84.00% of the companies in the same industry.
In the last couple of years the Profit Margin of CGTL has declined.
With an excellent Operating Margin value of 12.61%, CGTL belongs to the best of the industry, outperforming 84.80% of the companies in the same industry.
CGTL's Operating Margin has declined in the last couple of years.
CGTL has a worse Gross Margin (16.07%) than 70.40% of its industry peers.
In the last couple of years the Gross Margin of CGTL has declined.
Industry RankSector Rank
OM 12.61%
PM (TTM) 10.35%
GM 16.07%
OM growth 3Y-13.43%
OM growth 5YN/A
PM growth 3Y-15.14%
PM growth 5YN/A
GM growth 3Y-9.23%
GM growth 5YN/A
CGTL Yearly Profit, Operating, Gross MarginsCGTL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 5 10 15 20

More info and screens

10

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CGTL is creating value.
Compared to 1 year ago, CGTL has less shares outstanding
CGTL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CGTL Yearly Shares OutstandingCGTL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
CGTL Yearly Total Debt VS Total AssetsCGTL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

CGTL has an Altman-Z score of 10.69. This indicates that CGTL is financially healthy and has little risk of bankruptcy at the moment.
CGTL has a Altman-Z score of 10.69. This is amongst the best in the industry. CGTL outperforms 91.20% of its industry peers.
There is no outstanding debt for CGTL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 10.69
ROIC/WACC4.9
WACC8.83%
CGTL Yearly LT Debt VS Equity VS FCFCGTL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

CGTL has a Current Ratio of 5.39. This indicates that CGTL is financially healthy and has no problem in meeting its short term obligations.
CGTL has a Current ratio of 5.39. This is amongst the best in the industry. CGTL outperforms 84.80% of its industry peers.
CGTL has a Quick Ratio of 4.04. This indicates that CGTL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.04, CGTL belongs to the top of the industry, outperforming 84.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.39
Quick Ratio 4.04
CGTL Yearly Current Assets VS Current LiabilitesCGTL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 19.71% over the past year.
The Earnings Per Share has been growing by 22.21% on average over the past years. This is a very strong growth
Looking at the last year, CGTL shows a very negative growth in Revenue. The Revenue has decreased by -28.15% in the last year.
The Revenue has been growing by 41.14% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)19.71%
EPS 3Y22.21%
EPS 5YN/A
EPS Q2Q%44.18%
Revenue 1Y (TTM)-28.15%
Revenue growth 3Y41.14%
Revenue growth 5YN/A
Sales Q2Q%-29.17%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CGTL Yearly Revenue VS EstimatesCGTL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

CGTL is valuated cheaply with a Price/Earnings ratio of 3.14.
99.20% of the companies in the same industry are more expensive than CGTL, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CGTL to the average of the S&P500 Index (27.85), we can say CGTL is valued rather cheaply.
Industry RankSector Rank
PE 3.14
Fwd PE N/A
CGTL Price Earnings VS Forward Price EarningsCGTL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CGTL is valued cheaper than 97.60% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.43
CGTL Per share dataCGTL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

The decent profitability rating of CGTL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CGTL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CREATIVE GLOBAL TECHNOLOGY-A

NASDAQ:CGTL (5/1/2025, 8:51:32 PM)

After market: 0.935 +0.02 (+2.6%)

0.9113

+0.08 (+9.5%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.56%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap19.54M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.14
Fwd PE N/A
P/S 0.35
P/FCF N/A
P/OCF N/A
P/B 1.45
P/tB 1.45
EV/EBITDA 2.43
EPS(TTM)0.29
EY31.82%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS2.62
BVpS0.63
TBVpS0.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 35.61%
ROE 43.18%
ROCE 52.54%
ROIC 43.31%
ROICexc 44.78%
ROICexgc 44.78%
OM 12.61%
PM (TTM) 10.35%
GM 16.07%
FCFM N/A
ROA(3y)32%
ROA(5y)N/A
ROE(3y)40.9%
ROE(5y)N/A
ROIC(3y)40.34%
ROIC(5y)N/A
ROICexc(3y)54.15%
ROICexc(5y)N/A
ROICexgc(3y)54.15%
ROICexgc(5y)N/A
ROCE(3y)48.94%
ROCE(5y)N/A
ROICexcg growth 3Y-31.1%
ROICexcg growth 5YN/A
ROICexc growth 3Y-31.1%
ROICexc growth 5YN/A
OM growth 3Y-13.43%
OM growth 5YN/A
PM growth 3Y-15.14%
PM growth 5YN/A
GM growth 3Y-9.23%
GM growth 5YN/A
F-Score4
Asset Turnover3.44
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 22.66%
Cap/Sales 0.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.39
Quick Ratio 4.04
Altman-Z 10.69
F-Score4
WACC8.83%
ROIC/WACC4.9
Cap/Depr(3y)164.93%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.04%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.71%
EPS 3Y22.21%
EPS 5YN/A
EPS Q2Q%44.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-28.15%
Revenue growth 3Y41.14%
Revenue growth 5YN/A
Sales Q2Q%-29.17%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y16.76%
EBIT growth 3Y22.19%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-172.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-172.3%
OCF growth 3YN/A
OCF growth 5YN/A